This report is a summary of the results obtained from various molecular respiratory panels performed across PathCare laboratories during June 2024 (epidemiological weeks 23-26). The data is dependent on submission of samples by clinicians and therefore may not be representative of the general population but is intended to identify trends in the circulation of these viruses which may be of clinical relevance.
INFLUENZA, RESPIRATORY SYNCYTIAL VIRUS AND SARS-COV-2
- Following the peak of influenza A positivity noted in week 20, the detection rates declined during June, with national rates dropping from 33% in week 23 to 9% in week 26. Influenza A/H1 continued to be the predominant subtype detected among isolates for which molecular typing was available. Influenza B detection rates showed a slight increase, ranging from 8-11% during the reporting period.
- RSV detection rates remained at approximately 11% throughout June. The highest detection rates were noted in children aged <5 years, with percentage positivity ranging from 38-48% in 0-6 month olds, 30-35% in 6-12 months olds, and 16-20% in 1-5 year olds. RSV detection rates remained at or below 10% in all other age groups.
- As in May, SARS-CoV-2 percentage positivity was below 10% throughout the current reporting period.
Respiratory Pathogen Statistics: June 2024